Patricia A Lobelle-Rich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Patricia A Lobelle-Rich has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Chandtip Chandhasin
Christiana Hospital, 4755 Ogletown-Stanton Road, Newark, DE 19718, USA
1 shared publication - Laura S. Levy
Department of Microbiology and Immunology and Tulane Cancer Center, Tulane University School of Medicine, 1430 Tulane Avenue SL-38, New Orleans, LA 70112, USA
1 shared publication - Lisa L. Bolin
Department of Microbiology and Immunology, School of Medicine, Tulane University, 1430 Tulane Avenue SL-38, New Orleans, LA 70112, USA
1 shared publication - Lorraine M. Albritton
Department of Microbiology, Immunology and Biochemistry, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN, USA
1 shared publication
Latest Publications
- Open Access
- 13 May 2011
- Published by Springer Nature in Retrovirology
- Vol. 8 (1) , 35
Distinctive receptor binding properties of the surface glycoprotein of a natural Feline Leukemia Virus isolate with unusual disease spectrum
Feline leukemia virus (FeLV)-945, a member of the FeLV-A subgroup, was previously isolated from a cohort of naturally infected cats. An unusual multicentric lymphoma of non-T-cell origin was observed in natural and experimental infection with FeLV-945. Previous studies implicated the FeLV-945 surface glycoprotein (SU) as a determinant of disease outcome by an as yet unknown mechanism. The present studies demonstrate that FeLV-945 SU confers distinctive properties of binding to the cell surface receptor.
- 13 May 2011
- Published by Springer Nature in Retrovirology
- Vol. 8 (1) , 35
Open AccessDistinctive receptor binding properties of the surface glycoprotein of a natural Feline Leukemia Virus isolate with unusual disease spectrum
Feline leukemia virus (FeLV)-945, a member of the FeLV-A subgroup, was previously isolated from a cohort of naturally infected cats. An unusual multicentric lymphoma of non-T-cell origin was observed in natural and experimental infection with FeLV-945. Previous studies implicated the FeLV-945 surface glycoprotein (SU) as a determinant of disease outcome by an as yet unknown mechanism. The present studies demonstrate that FeLV-945 SU confers distinctive properties of binding to the cell surface receptor.